Publicacions en col·laboració amb investigadors/es de Universidad Miguel Hernández de Elche (13)

2024

  1. Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom

    Journal of Venomous Animals and Toxins Including Tropical Diseases, Vol. 30

2023

  1. Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

  2. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  3. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2022

  1. Considerations for Clinical Use of Mesenchymal Stromal Cells

    Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102

  2. Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019

    The Lancet Regional Health - Americas, Vol. 15

  3. Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide

    Antioxidants, Vol. 10, Núm. 9

2020

  1. AICAR stimulates the pluripotency transcriptional complex in embryonic stem cells mediated by PI3K, GSK3β, and β-Catenin

    ACS Omega, Vol. 5, Núm. 32, pp. 20270-20282

  2. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  3. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming

    Frontiers in Immunology, Vol. 11

2017

  1. Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis

    PLoS ONE, Vol. 12, Núm. 11